BioTech, Exercises and Health Policy - Connected Health Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

BioTech

Exercises

Health Policy

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

OCTOBER 28, 2019

If surprise medical bills, out-of-network hassles, and waiting times for services persist, we may see this happen as patients-as-payors exercise their consumer muscles. Will consumers cross that cost-and-trust chasm and express similar outrage with the hospital sector as they’ve shown for a decade vis-a-vis Big Pharma?

Pharmaceuticals

Pharmaceuticals Medical Billing Medicare Mental health

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

JULY 1, 2019

When this occurred, it didn’t cause more than a ripple of interest outside biotech. To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. But the U.S. citizens’ personal data.

Pharmaceuticals

Pharmaceuticals HIPAA BioTech Patient Experience

Webinars

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Less Stress, More Success: Accounting Best Practices & Processes for 2025

MORE WEBINARS

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Webinars

Stay Connected